Summa Bio-Solutions

Prof Demosthenes Bouros is a graduate of the Medical School of the Aristotelian University of Thessaloniki (1975) and a PhD of the University of Athens (1988). He was a research fellow at the Harvard University in Boston and Visiting Assistant Professor at the Boston University (1986-1988). He spent his sabbatical as a Senior Research Associate at the Royal Brompton Hospital, and the National Heart and Lung Institute-Interstitial Lung Disease Unit at the Imperial College of London, UK (1998-1999). He elected assistant Professor in Pneumonology at the Medical School, University of Crete (1989), associate Professor (1995-2002) and Professor of Pneumonology at the University of Thrace, Greece (2002-). European Respiratory Society Visiting professor at the Medical University of Vienna (2010). He served as vice chair/chair of the Department of Pneumonology at the University of Crete and the University Hospital of Heraklion, Greece. He also served as director of the Emergency Department, and chairman of the Department of internal medicine at the University Hospital of Heraklion, Crete and member of the University of Crete Senate. Currently, he is Professor of Pneumonology at the University of Thrace and head of the Department of Pneumonology at the University Hospital of Alexandroupolis. He is also serves as chairman of the Dept of Internal Medicine of the University Hospital of Alexandroupolis and chairman of the Dept of Internal Medicine of the Democritus University of Thrace. He is member of the board of the Medical School of the Democritus University of Thrace, the University Hospital of Alexandroupolis, and the National Council of Health (KESY). He is author of a book entitled ‘Basic principles of clinical pharmacology and therapeutics’ (1999 and 2005 2nd ed.), editor of a book entitled “Pleural Diseases” (Marcel Dekker NY, 2004, and 2nd ed, Informa NY, 2009) of the series Lung Biology on Health and Disease published by the NIH (USA). He has published >400 articles in national and international peer-review journals, has >4300 citations, H index 36, he wrote >40 chapters in books in Greek and English, is member of the 2 Editorial Board of many medical journals (EIC: Pneumon, Associate Editor: RESPIRATION, BMCPulmonary Medicine, BMC-research notes; EB member: CHEST, Eur Respir Topic, Future Drugs, Newsletter on Pleural Disease, etc), reviewer in many journals (including Lancet, BMJ, AJRCCM, ERJ, Chest, Thorax, PMJ, EJCI, Respir Med, BMC series, Tubercle, ICM), and member of many international medical societies (ERS, ATS, ACCP, WASOG, ACC Pharmacology, etc). He has been section editor for pleural diseases update (Respiration, 2008) and interstitial lung diseases (Current Opinion in Pulmonary Medicine, 2011). He participated in the development of the European Respiratory Society (ERS) official statements for COPD (1995), Tuberculosis management in Europe (1999) and Interstitial Lung Disease (2001). He was a member of the committee for the development of the new ATS/ERS/JRS guidelines for idiopathic pulmonary fibrosis (2007-2010) and the new classification of idiopathic interstitial pneumonias (2010-2012). Is reviewer for the published ERS consensus statement for lymphangioleiomyomatosis (LAM, 2010). He collaborates with many scientists in Europe and the US. He has been elected and served as National Delegate at of the ERS (1999-2003), was a member of the council and the nomination committee of the ERS (2002-2003), and a member of the long-range planning committee of the American Thoracic Society (ATS) and the ERS. He served as auditor of the ERS (2004-2007) and is a member of the Assembly on Allergy, Inflammation and Immunology (AII) Program Committee of the ATS. His main research interests include the pathophysiologic/pathogenetic mechanisms and treatment of interstitial lung diseases and the pleural diseases.